ENT Devices Market Size, Share & Trends Report

ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic Devices, Surgical Devices, Nasal Splints), By Region, Vendor Landscape, And Segment Forecasts, 2012 - 2022

  • Published Date: May, 2018
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-477-2
  • Format: Electronic (PDF)
  • Historical Data: 2012 - 2014
  • Number of Pages: 159

Report Overview

The global ENT devices market size was valued at USD 17.2 billion in 2016. It is estimated to progress at a CAGR of 5.0% over the forecast period. Rising geriatric population, increasing prevalence of ENT related disorders, growing government initiatives are among the key trends stimulating market growth. Technological advancements also play an important role in the growth of the market.

U.S. ENT devices market

Widening base of geriatric population worldwide is leading to increased prevalence of age-related illnesses such as hearing loss and decrease in functioning levels of ENT. This, in turn, is expected to augment the market. Rising disposable income and well-established healthcare infrastructure are also projected to work in favor of the market.

Rise in age also causes weak immunity system, which makes older people more susceptible to infections such as sore throat. According to the Action on Hearing Loss Information, one out of every six people or over 10 million people in the U.K. suffered from hearing loss. Out of these, 6.4 million people belonged to the age group of 65 and above and 800,000 people suffered from severe or profound deafness.

Hearing service offices and general healthcare service associations of local governments, in both developed and developing economies, are raising their emphasis on early screening of hearing loss and dispensing of hearing aids to its people. As the healthcare sector in emerging economies move towards privatization, the healthcare infrastructure in these regions is also developing rapidly.

Education and increased awareness about health and wellbeing among the general population is also playing a critical role in spurring the demand for hearing aids and diagnostic services globally. Subsidies, grants, and funding are offered by several governments across the world to prevent and manage ENT disorders. These factors are poised to stoke the growth of the market over the forecast period.

Spiraling adoption rates of ENT devices, impairments due to usage of aesthetic products, increasing awareness among patients and healthcare professionals, and rising trend for nasal correction procedures are anticipated to trigger the growth of the market. Growing adoption of user-friendly material in manufacturing of these devices are also likely to benefit the market.

Product Insights

On the basis of product, the market can be segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, and nasal splints. In 2015, hearing aids accounted for the largest revenue share in the market. Rising prevalence of hearing loss and disability is translating into greater usage of latest technologies to allow audiologists to better understand and treat these diseases. In addition, introduction of user-friendly and technologically advanced devices is contributing to the growth of the segment.

Global ENT devices market

Hearing implants are estimated to be the fastest growing product segment over the forecast period. The growth of the segment can be attributed to increasing awareness among target consumers, introduction of technological advanced systems, and improving healthcare infrastructure in developing regions. For instance, Sound World Solutions manufactured CS10, which is integrated with iPhone and Bluetooth and is developed to amplify sound for non-hearing-impaired patients using its customization app. It provides users with enhanced listening experience.

Regional Insights

North America was the key revenue contributor in 2015. Presence of high awareness levels among practitioners and patients, well-established healthcare infrastructure, and favorable government initiatives are some of the primary factors supplementing the growth of the ENT devices market in the region. Europe is the second largest region and has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels.

Asia Pacific is expected to show the fastest growth over the forecast period due to rising disposable income and presence of a wide base of target population. Besides this, expansion of distribution network of major players in this region and increasing awareness about ENT disorders are supporting the growth of the regional market.

Large international firms such as Belton and Widex are setting up retail stores in India due to immense potential of the retail sector in China and India and growing purchasing power of patients. Prices of ENT devices are projected to reduce in future and hence, leading to an increase in the usage of these devices.

Key Companies & Market Share Insights

Some of the prominent companies operating in the market are Siemens Healthcare; Widex A/S; Atos Medical AB; Starkey Laboratories Inc.; GN ReSound A/S; William Demant Holding A/S; Sonova Holding AG; Cochlear Limited; Rion Co.; Ltd.; and Welch Allyn.

Launch of technologically advanced devices, such as micro hand instruments by Stema Medizin, bone-anchored hearing aids (BAHA), and Phonak Audeo V by Sonova by Nobel Biocare is poised to provide a tremendous push to the market. The market provides a varied scope for development of cost-effective, safe, and user-friendly treatment options for patients.

ENT Devices Market Report Scope

Report Attribute


Market size value in 2020

USD 13.9 billion

Revenue forecast in 2022

USD 23.1 billion

Growth Rate

CAGR of 5.0% from 2016 to 2022

Base year for estimation


Historical data

2012 - 2014

Forecast period

2016 - 2022

Quantitative units

Revenue in USD million and CAGR from 2016 to 2022

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, region

Regional scope

North America; Europe; APAC; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; France China; Japan; Brazil; Mexico; South Africa

Key companies profiled

Siemens Healthcare; Widex A/S; Atos Medical AB; Starkey Laboratories Inc.; GN ReSound A/S; William Demant Holding A/S; Sonova Holding AG; Cochlear Limited; Rion Co., Ltd.; Welch Allyn

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research has segmented the global ENT devices market report on the basis of product and region:

  • Product Outlook (Revenue, USD Million, 2012 - 2022)

    • Diagnostic Ear, Nose, And Throat (ENT) Devices

      • Rigid Endoscopes

        • Rhinoscopes

        • Laryngoscopes

        • Otological Endoscopes

      • Flexible Endoscopes

      • Robot Assisted Endoscope

      • Hearing Screening Device

    • Surgical Ear, Nose, And Throat (ENT) Devices

      • Radiofrequency Handpieces

      • Powered Surgical Instrument

      • Otological Drill Burrs

      • ENT Hand Instruments

      • Tympanostomy Tubes

      • Sinus Dilation Devices

      • Nasal Packing Devices

    • Hearing Aids Ear, Nose, And Throat (ENT) Devices

      • Behind-the-Ear (BTE) aids

      • In-the-Ear aids

      • Receiver-in-the-Ear (RITE)

      • Canal hearing aids ITC, CIC and IIC

    • Hearing Implants Ear, Nose, And Throat (ENT) Devices

      • Auditory Brainstem Implants

      • Cochlear Implants

      • Middle Ear Implants

      • Bone Anchored Hearing System

    • Nasal Splints Ear, Nose, And Throat (ENT) Devices

      • Internal Nasal Splints

      • External Nasal Splints

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPA norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities